Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hyperglycemia
Phenotype |diabetes mellitus
Sentences 78
PubMedID- 22247866 Several drugs such as biguanides and sulfonylureas are presently available to reduce hyperglycemia in diabetes mellitus.
PubMedID- 24808678 [5] complications due to hyperglycemia in diabetes mellitus can be prevented by using rational use of oral antidiabetic drugs (oads) and insulin.
PubMedID- 22842610 Self-monitoring of blood glucose is the standard of care in management of hyperglycemia among patients with diabetes mellitus.
PubMedID- 21046527 Aleglitazar, being developed by roche holding, is a dual agonist for ppargamma and pparalpha for the potential simultaneous treatment of hyperglycemia and dyslipidemia in patients with type 2 diabetes mellitus (t2dm).
PubMedID- 22071577 diabetes mellitus, a state of persistent hyperglycemia, is a major cause of micro- and macrovascular diseases.
PubMedID- 22086363 In the surgical population, hyperglycemia with or without diabetes mellitus may be unrecognized.
PubMedID- 25284699 Glucagon-like peptide-1 receptor (glp-1) agonists and dipeptidyl-peptidase-4 (dpp-4) inhibitors are therapies that are used to treat hyperglycemia in patients with type 2 diabetes mellitus.
PubMedID- 24375463 Introduction: hyperglycemia associated with diabetes mellitus (dm) has adverse impacts on peripheral nerve connective tissue structure, and there is preliminary evidence that nerve biomechanics may be altered.
PubMedID- 21341505 Nonenzymatic glycation of proteins or maillard reaction is increased in diabetes mellitus due to hyperglycemia and leads to several complications such as blindness, heart disease, nerve damage and kidney failure.
PubMedID- 23320026 hyperglycemia associated with diabetes mellitus can be controlled by diet management, exercise, oral hypoglycemic agents, and insulin therapy.
PubMedID- 20876838 Managing hyperglycemia in patients with type 2 diabetes mellitus: rationale for the use of dipeptidyl peptidase-4 inhibitors in combination with other oral antidiabetic drugs.
PubMedID- 20649531 diabetes mellitus (dm), a state of chronic hyperglycemia, is associated with a variety of serious complications.
PubMedID- 21159853 After extending previous evidence that leptin infusion directly into the lateral cerebral ventricle ameliorates hyperglycemia in rats with streptozotocin-induced uncontrolled diabetes mellitus, we showed that the underlying mechanism is independent of changes of food intake, urinary glucose excretion, or recovery of pancreatic beta-cells.
PubMedID- 24341330 The persistent hyperglycemia in patients with type 2 diabetes mellitus is strongly associated with microvascular and macrovascular complications [1].
PubMedID- 22745633 hyperglycemia in individuals with diabetes mellitus usually compromises myocardial contractile function and energy metabolism independent of macro- and microvascular coronary anomalies [1–4].
PubMedID- 22911800 hyperglycemia in diabetes mellitus damages blood vessels and induces vascular complications in the retinal, renal, and cardiovascular tissues [1], [2].
PubMedID- 25918533 A 30-year-old obese male patient had been diagnosed with diabetes mellitus due to acute hyperglycemia and ketonuria.
PubMedID- 26141922 hyperglycemia in diabetes mellitus causes glycation of membrane enzymes along with oxidative stress leading to decrease in activity of na+/k+-atpase and other changes in erythrocyte membranes [1].
PubMedID- 22611498 Endothelial dysfunction associated with insulin resistance appears to precede the development of overt hyperglycemia in patients with type 2 diabetes mellitus [100, 101].
PubMedID- 23209008 Finally, it attempts to integrate these mechanisms into the schema of pathophysiological factors that combine to produce hyperglycemia in patients with diabetes mellitus.
PubMedID- 25705228 To prevent worsening hyperglycemia with underlying diabetes mellitus, steroids were avoided and the patient was started on an immunosuppressant, azathioprine.
PubMedID- 26343954 Enhanced oxidative stress and hyperglycemia are associated with diabetes mellitus (dm).
PubMedID- 24857350 Background: chorea is a common presenting feature of metabolic disorders, including nonketotic hyperglycemia in patients with type 2 diabetes mellitus, but rarely has been reported in diabetic ketoacidosis, hypothyroidism and vitamin b12 deficiency.
PubMedID- 21521130 Introduction: in preliminary clinical studies, aleglitazar, a new dual ppar-alpha-gamma agonist, has been demonstrated to improve hyperglycemia and dyslipidemia in patients with type 2 diabetes mellitus.
PubMedID- 25633134 Among the many complications of type 2 diabetes mellitus (t2dm) arising from prolonged hyperglycemia, as well as from comorbid conditions such as hypertension, is chronic kidney disease (ckd), which is present in up to 40% of patients with t2dm [1].
PubMedID- 22699799 hyperglycemia occurs in patients with poorly controlled diabetes mellitus and contributes to bone resorption and increased susceptibility to bacterial infections.
PubMedID- 23816355 Exercise has been widely recognized to ameliorate insulin resistance and hyperglycemia in individuals with type 2 diabetes mellitus (t2dm) [1,2].
PubMedID- 21713142 Experimental diabetes mellitus-induced hyperglycemia produced a significant decrease in tail flick latency time.

Page: 1 2